HEAT BIOLOGICS, INC. [●] Shares of Common Stock and Warrants to Purchase Up to [●] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 15th, 2016 • Heat Biologics, Inc. • Pharmaceutical preparations • New York
Heat Biologics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC and Aegis Capital Corporation are acting as the representatives (the “Representatives”), an aggregate of [●] shares (the “Shares”) of common stock, par value $0.0002 per share (the “Common Stock”), of the Company and warrants (the “Warrants”) to purchase up to [●] shares of Common Stock (the “Warrant Shares”) at an exercise price of $[●] per share. Each Share is being sold together with 0.50 of a Warrant to purchase one Warrant Share. The Shares, the Warrants and the Warrant Shares are collectively referred to as the “Securities”.
